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Abstract: Juvenile delinquency is related to several biological factors, yet very few vulnerability
biomarkers have been identified. Previous data suggest that the enzyme monoamine oxidase
B (MAO-B) influences several personality traits linked to the propensity to engage in delinquent
behavior. Building on this evidence, we assessed whether conduct disorder (CD), juvenile delinquency
adjudications, or detention in a correctional facility were associated with either platelet MAO-B
activity or the MAOB rs1799836 polymorphism. The study enrolled 289 medication-free male youths,
including 182 individuals detained in a correctional facility (with or without a diagnosis of CD). Of the
remaining 107 participants, 26 subjects had a diagnosis of CD, and 81 were mentally healthy controls.
Platelet MAO-B activity was determined by spectrophotofluorometry, while MAOB rs1799836 was
genotyped using qPCR. Platelet MAO-B activity, corrected for age and smoking, was significantly
higher in juvenile detainees (p < 0.001), irrespective of CD diagnosis. MAOB rs1799836 was not
associated with platelet MAO-B activity or with detention in a correctional facility, CD diagnosis,
or delinquent behavior. These data suggest that detention in a juvenile correctional facility increases
platelet MAO-B activity in male adolescents. Future studies are needed to determine the mechanisms
and functional significance of MAO-B peripheral elevation in juvenile male detainees.
Keywords: juvenile correctional facility; delinquent behavior; platelet MAO-B activity; MAOB
rs1799836 polymorphism; conduct disorder
1. Introduction
Conduct disorder (CD) is a persistent pattern of antisocial and disruptive behaviors in children
and adolescents, characterized by harmful behavior towards animals and people, disregard for the
rights and properties of others, and violation of societal norms [1–3]. In line with male preponderance
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of aggression and antisocial behavior, the prevalence rate of CD is higher in males than females [3,4].
Given the robust association of CD with juvenile delinquency, about 38% of juvenile male detainees
meet diagnostic criteria for this disorder [5].
Recent evidence has shown that the ontogeny of CD and delinquent behavior is robustly
influenced by biological factors [6,7], yet the molecular underpinnings of this condition remain poorly
understood. Previous research has shown that both internalizing and externalizing psychopathologies
in male juvenile delinquents were associated with low platelet activity of monoamine oxidase type
B (MAO-B) [8], one of the two enzymes that catalyze the oxidative deamination of monoaminergic
neurotransmitters [9]. Consistently, reduced platelet MAO-B activity was found to be associated with
delinquent and criminal behaviors [10,11], poor impulse control, extraversion, as well as predisposition
for risky, impulsive, sensation-seeking, and novelty-seeking behaviors [10,12,13]. In keeping with
these results, genetic deficiency of MAO-B in mice was found to be associated with behavioral
disinhibition [14].
Preliminary evidence supports that platelet MAO-B activity may be a heritable factor [15]. One of
the best-characterized MAOB polymorphisms is rs1799836, consisting of an A to G substitution,
and located in intron 13 of this gene, 36 bp upstream from the boundary with exon 14 [16].
This polymorphism has been associated with different risk for CD-related psychopathological states.
For example, Netter and colleagues [17] reported that, in alcohol-dependent patients, the G genotype
was associated with higher aggression scores than A- allele carriers, even though this finding was not
confirmed by a study performed on a much larger cohort [18].
Building on these premises, this study was aimed at evaluating whether platelet MAO-B activity
and MAOB rs1799836 polymorphism were associated with CD diagnosis, delinquency (defined as
a conviction for criminal offenses), and detention in a correctional facility in a cohort of male youths.
2. Materials and Methods
2.1. Participants
This study included 289 young male drug-naive subjects, subdivided as follows: 182 subjects
detained in the Juvenile Correctional Facility Ivanec, Zagreb County, Croatia (age: 16.7 ± 0.18 years
old), with (N = 117) and without (N = 65) diagnosis of CD; 26 outpatients (i.e., out of detention) with
CD (age: 15.0 ± 0.41 years old); and 81 mentally healthy controls (13.7 ± 0.24 years old). The last two
cohorts were recruited during their regular medical examination at the Family Medicine Unit in Osijek,
Croatia, or the Department of Child and Adolescent Psychiatry in the Clinical Hospital Centre, Osijek.
Among the juvenile detainees, 86 had no history of convictions, while the other 96 (hereafter
referred to as “subjects with court convictions”) had records of delinquency adjudications. To evaluate
different aggressive/dissociative behaviors, Hare Psychopathy Checklist: Youth Version (PCL-YV),
Overt Aggression Scale-Modified (OAS-M), and Child Behavior Checklist (CBCL) were used [19–21].
Diagnoses of CD were confirmed by a team of child psychiatrists, and a psychologist, according to
the Structured Clinical Interview for DSM-IV criteria (SCID-IV) [22]. Smoking status was determined by
a questionnaire; subjects were classified as smokers (N = 124) or nonsmokers (N = 165). All participants
were medication-free. The following exclusion criteria were used: use of psychoactive compounds
or alcohol; diagnosis of autism spectrum disorder, intellectual disability or ADHD, and a treatment
history of cognitive behavioral therapy or electroconvulsive therapy. Control youth did not have any
psychiatric diagnosis. All participants gave voluntary informed consent to be a part of the study.
The study was approved by the Ethics Committees in each institution, and was fully compliant with
the ethical standards laid down in the 1975 Declaration of Helsinki.
2.2. Determination of Platelet MAO-B Activity
Whole blood samples were collected in 8.5 mL yellow-top Vacutainer tubes (Becton, Dickinson and
Company, Franklin Lakes, NJ, USA) with 1.5 mL of acid citrate dextrose anticoagulant. Sampling was
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done in the morning around 8 a.m., after overnight fasting. Platelets were obtained from whole blood
by a series of centrifugation steps and broken by sonication. Platelet MAO-B activity was determined
in all participants as previously described [23] with a slightly modified method described by Krajl [24]
and using kynuramine (Sigma-Aldrich, St. Louis, MS, USA) as a substrate. Spectrophotofluorometric
determination of MAO-B was performed on a Varian Cary Eclipse fluorescence spectrophotometer
(Varian, Palo Alto, CA, USA), with excitation wavelength of 310 nm and emission range of 380 nm.
Platelet protein levels were measured by the method of Lowry [25]. Platelet MAO-B activity was
calculated using the standard curve of 4-hydroxyquinoline (4-OHQ; Sigma-Aldrich, St. Louis, MS,
USA) and expressed in nmol of 4-OHQ formed per hour, per mg of total platelet proteins.
2.3. Genotyping of MAOB rs1799836 Polymorphism
Extraction of genomic DNA was carried out with the salting-out method [26]. MAOB intron
13 A/G polymorphism (rs1799836) was determined with real-time PCR according to the procedures
described by Applied Biosystems. Genotyping was done with an ABI Prism 7300 Real-time PCR
System apparatus (Applied Biosystems, Foster City, CA, USA), using primers and probes from Applied
Biosystems (Foster City, CA, USA) as TaqMan® SNP Genotyping Assay (C_8878790_10). Graphical
presentation of real-time PCR data is shown as supplementary material (Figure S1). Genotyping was
done by a researcher blinded to all clinical data. Around 10% of the samples were re-genotyped for
quality control.
2.4. Statistical Analysis
Results were expressed as numbers and percentages or median and range (minimum and
maximum) and evaluated with Sigma Stat 3.5 (Jandel Scientific Corp., San Jose, CA, USA). Normality
of distribution was assessed with the Kolmogorov–Smirnov test. Multiple linear regression analysis
was used to assess the influence of CD diagnosis, age, smoking, and MAOB rs1799836 on platelet
MAO-B activity. Comparison of platelet MAO-B activity and age between different groups of subjects
was made using Kruskal–Wallis ANOVA by ranks or Mann–Whitney U test, since normality of the
data failed. Allele frequencies were compared using χ2-test and Yates correction for continuity. As the
study included only male subjects, we could not determine Hardy–Weinberg equilibrium for MAOB
rs1799836, since MAOB is located on the X chromosome. All tests were two-tailed, and αwas set at
0.025 (as we tested the significance of two variables, namely platelet MAO-B and MAOB rs1799836).
G*Power 3 Software [27] was used to determine a priori sample size. For ANOVA (with α = 0.025;
power (1−β) = 0.800; medium effect size (ω = 0.25) and 4 groups), total desired sample size was 180; for
genetic analyses and χ2-test (with α = 0.025; power (1−β) = 0.800 and medium effect size (ω = 0.30);
with df = 1, total desired sample size was 106; and with df = 2, total desired sample size was 128;
for Mann–Whitney test (with α = 0.025; power (1−β) = 0.800; medium effect size (ω = 0.50), total
desired sample size was 128; and for multiple regression analysis (with α = 0.025; power (1−β) = 0.800;
medium effect size (ω = 0.15); number of predictors = 3), total desired sample size was 91. Therefore,
the study included an adequate sample size, and the statistical power was appropriate to detect
significant differences in the studied groups.
3. Results
Given that age and smoking have a potent effect in increasing and reducing MAO-B activity,
respectively [10,28,29], we controlled for these factors as in our previous analyses [18,23,30]. Juvenile
detainees with or without CD were significantly older (F = 94.30; df = 3; p < 0.0001; p < 0.001;
Kruskal–Wallis ANOVA) than patients with CD or healthy controls. Furthermore, the number of
smokers was higher than that of nonsmokers (χ2 = 139.21; df = 3; p < 0.0001). To rule out potential
confounding effects of age and smoking on platelet MAO-B activity, multiple linear regression
analysis was performed, with platelet MAO-B activity as the dependent variable and age and
smoking as independent variables. This analysis showed no significant effects of age (p = 0.343) or
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smoking (p = 0.619) on platelet MAO-B activity (F(2,286) = 0.453; p = 0.636; Radj2 = −0.004). Thus,
in further analyses, groups were not subdivided into smokers and nonsmokers or according to the age
of participants.
Platelet MAO-B activity was not related to a diagnosis of CD, since it did not differ significantly
between youths from a correctional facility with or without CD (p = 0.755), or between healthy
subjects and patients with CD (p = 0.988). Conversely, our analyses showed that this index was
associated with correctional facility detention. Indeed, platelet MAO-B activity was significantly higher
(H = 14.088; df = 3; p = 0.003; Kruskal–Wallis ANOVA) in detainees with or without CD compared to
healthy controls and patients with CD (Figure 1). Dunn’s test revealed that detainees with (p = 0.001)
and without CD (p = 0.011) had significantly higher platelet MAO-B activity than healthy controls.
Platelet MAO-B was also significantly increased in all 182 detainees compared to 81 healthy controls
(U = 9,276.50; p = 0.001; Mann–Whitney test). A statistical trend for higher platelet MAO-B activity
(p = 0.030, not fully significant due to the p correction) was also evidenced in the comparison of
detainees vs. outpatients with CD.
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between detainees who committed or who did not commit property crime (U = 3845.5; p = 0.838;
Mann–Whitney test).
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To evaluate why higher platelet MAO-B activity was associated only with juvenile detention,
we studied the potential association between platelet MAO-B activity and dissociative/aggressive/
delinquent behavior (determined by PCL-YV, OAS-M and CBCL) in all detainees (Table 1) using
multiple linear regression. This analysis revealed that platelet MAO-B activity, corrected for smoking
and group affiliation (healthy subjects vs. patients with CD vs. youths from a correctional facility with
or without CD), was significantly affected (F(2,180) = 6.95; p = 0.001; Radj2 = 0.09) only by the scores in
OAS-M item verbal aggression (p = 0.016), but not by other symptoms/scores, as determined by the
PCL-YV, other OAS-M items, and CBCL (Table 1). These results collectively suggest that living in a
correctional facility was the main factor associated with increased platelet MAO-B activity.
To evaluate whether the presence of the G or A allele of the MAOB rs1799836 polymorphism
affects platelet MAO-B activity, we performed a multiple linear regression analysis, with platelet
MAO-B activity as the dependent var able and group affiliation (healthy subjects vs. patients with
CD vs. youths from a correctional facility with or without CD) and MAOB rs1799836 as independent
variables. In agreement with previous results, th s analysis revealed no significant ffec of MAOB
rs1799836 polymorphism (p = 0.746) and a significant effect of group affiliation (p = 0.004) on platelet
MAO-B activity (F(2,284) = 4.31; p = 0.014; Radj2 = −0.023).
The frequ ncy (χ2 t st) of the A and G alleles of MAOB rs1799836 did not differ significantly
(p = 0.810) between healthy controls, youths with CD from a correctional facility, juvenile detainees
without CD, and patients with CD (Table 2), or between detainees with or without court convictions
(p = 0.862), detainees who did or who did not attempt to commit murder (p = 0.167) or detainees who
committed or who did not commit property crime (p = 0.734; Table 3).
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Table 1. Multiple linear regression with platelet MAO-B activity and number of scores of
aggressive/dissociative/delinquent behaviors evaluated using Hare Psychopathy Checklist: Youth
Version (PCL-YV), Overt Aggression Scale-Modified (OAS-M), and Child Behavior Checklist (CBCL)
in detainees.
Scales for Evaluating
Dissociative/Aggressive/Delinquent
Behavior
MAO-B Activity Multiple Linear Regression Model
Coefficient t p Corrected R2 F p
PCL-YV: total 0.001 0.01 0.994 0.060 4.81 0.003
Factor 1 0.596 1.22 0.222 0.067 5.36 0.001
Factor 2 0.224 0.49 0.625 0.061 4.91 0.003
Factor 3 −0.121 −0.27 0.791 0.060 4.85 0.003
Factor 4 −0.939 −1.65 0.101 0.074 5.80 0.001
(F1+F2)/(F3+F4) 0.816 0.56 0.573 0.061 4.94 0.003
OAS-M: total 0.100 1.39 0.168 0.070 5.52 0.001
Verbal aggression 0.669 2.43 0.016 0.090 6.95 <0.001
Aggression against property 0.051 0.24 0.807 0.060 4.85 0.003
Physical aggression against property or
objects 0.201 1.27 0.206 0.068 5.40 0.001
Physical aggression against self 0.115 0.42 0.672 0.061 4.91 0.003
CBCL: total 0.001 0.02 0.982 0.060 4.82 0.003
Delinquency (D) 0.182 0.71 0.478 0.062 5.01 0.002
Aggression (A) −0.027 −0.19 0.849 0.060 4.84 0.003
A/D −0.01 −0.02 0.986 0.063 4.96 0.003
Table 2. MAOB rs1799836 allele frequency in male medication-naive youths who were subdivided into
healthy controls, young patients with conduct disorder (CD), and youths from a juvenile correctional
facility without CD and with CD.
Subjects
MAOB rs1799836
Allele A
N (%)
Allele G
N (%)
Healthy controls 46 (56.8) 35 (43.2)
Youth with CD 14 (56.0) 11 (44.0)
Youth from the juvenile correctional facility Without CD 37 (56.9) 28 (43.1)
With CD 59 (50.9) 57 (49.1)
Test statistics X2 = 0.96; df = 3; p = 0.810
Table 3. MAOB rs1799836 allele frequency in male medication-naive youths who were subdivided into
youths with or without court convictions, detainees with or without a record of attempted murder,
and detainees who committed or who did not commit property crime.
Youth from the Juvenile Correctional Facility
MAOB rs1799836 χ
2 test
(df = 1)
Allele A
N (%)
Allele G
N (%) χ
2 p
Court convictions
No 44 (51.8) 41 (48.2)
0.03 0.862Yes 52 (54.2) 44 (45.8)
Attempted murder No 81 (50.9) 78 (49.1) 1.67 0.167Yes 15 (68.2) 7 (31.8)
Property crime No 61 (51.7) 57 (48.3) 0.12 0.734Yes 35 (55.6) 28 (44.4)
To evaluate the possible association between MAOB rs1799836 alleles with delinquent behavior,
multiple linear regression, corrected for smoking and group affiliation (healthy subjects vs. patients
with CD vs. youths from a correctional facility with or without CD), was used, with MAOB rs1799836
as the independent variable and the scores on PCL-YV, OAS-M and CBCL as dependent variables in
all detainees (Table 4). The results of multiple linear regression with MAOB rs1799836 and PCL-YV,
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OAS-M, and CBCL scores in detainees revealed that MAOB rs1799836 was not significantly (Table 4)
associated with the presence of aggressive/dissociative/delinquent symptoms or behaviors assessed by
these scales. These results collectively suggested that MAOB rs1799836 was not significantly associated
with juvenile detention, diagnosis of CD, and/or delinquent behavior in male youths.
Table 4. Multiple linear regression with MAOB rs1799836 and number of scores of aggressive/
dissociative/delinquent behaviors evaluated using Hare Psychopathy Checklist: Youth Version
(PCL-YV), Overt Aggression Scale-Modified (OAS-M), and Child Behavior Checklist (CBCL)
in detainees.
Scales for Evaluating
Dissociative/Aggressive/Delinquent
Behavior
MAOB rs1799836 Multiple Linear Regression Model
Coefficient t p Corrected R2 F p
PCL-YV: total −0.674 −0.60 0.550 0.433 69.61 <0.001
Factor 1 −0.059 −0.17 0.864 0.331 45.42 <0.001
Factor 2 0.035 0.09 0.925 0.244 30.11 <0.001
Factor 3 −0.550 −1.49 0.137 0.314 42.14 <0.001
Factor 4 −0.111 −0.38 0.707 0.471 81.06 <0.001
(F1+F2)/(F3+F4) 0.147 1.25 0.214 0.001 1.07 0.346
OAS-M: total 0.280 0.47 0.641 0.191 22.23 <0.001
Verbal aggression 0.739 0.91 0.363 0.137 15.30 <0.001
Aggression against Property −1.102 −1.04 0.299 0.153 17.23 <0.001
Physical aggression against property or
objects −0.244 −0.34 0.698 0.072 8.01 <0.001
CBCL: total −2.762 −0.92 0.358 0.328 44.83 <0.001
Delinquency (D) −0.301 −0.45 0.654 0.417 65.36 <0.001
Aggression (A) −0.297 −0.25 0.805 0.393 59.15 <0.001
A/D 0.251 0.77 0.444 −0.008 0.30 0.743
4. Discussion
This study examined the association of platelet MAO-B activity and MAOB rs1799836
polymorphism with CD, delinquent behavior, and juvenile detention in male youths, as compared
with CD outpatients and healthy controls. Our main findings showed that while platelet MAO-B
activity was not associated with either CD or a positive history of delinquency, it was associated with
detention in a correctional facility, irrespective of a diagnosis of CD. This finding persisted even after
platelet MAO-B activity was controlled for the effect of smoking and age. Finally, no associations were
found between these indices and MAOB rs1799836.
The lack of significant associations between CD and platelet MAO-B activity confirms and
expands previous evidence documenting the lack of associations between this index with symptoms of
disruptive behavior symptoms in boys [31] or with measures of childhood behavioral disorders in
forensic psychiatric patients with a history of recidivistic violent crimes [32].
We detected increased platelet MAO-B activity in association with juvenile detention. On the
surface, these results may appear at odds with previous findings on the lower platelet MAO-B activity
in imprisoned individuals who committed violent crimes [33–35], former juvenile delinquents who
developed persistent criminality in adulthood [36], violent male prisoners detained for homicide,
assault, or robbery [37], and male prisoners with a history of heavy criminality and with personality
disorders (paranoid, schizotypal and schizoid, antisocial, borderline, histrionic, and narcissistic) [35].
Nonetheless, our data substantiated that the elevation in MAO-B activity was observed in detained
subjects irrespective of their delinquency record, raising the possibility that higher MAO-B levels
are a consequence of, rather than a risk factor for, detention in a correctional facility. In line with
this interpretation, we found no association of MAO-B activity with delinquent behavior, as revealed
by their delinquency adjudication record, or specific crimes, such as attempted murder or property
violation. Furthermore, MAO-B activity was not associated with any index of different facets of
delinquent behavior and psychopathy, with the only exception of verbal aggression evaluated by the
OAS-M. This finding is also in accord with previous results showing a lack of association between
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platelet MAO-B and violent acts (homicide or not), history of suicide attempt, and history of heroin
use [37], or indices of psychosocial adversity or crime-related factors, such as scores on the Life History
of Aggression Scale and the Psychopathy Checklist [32], or with or without criminal recidivism [11].
It should be stated, however, that other reports documented a correlation of platelet MAO-B activity
with criminal behavior in adolescents exposed to early life stress; this correlation disappeared in
adolescents living in more favorable conditions, suggesting that this interaction is affected by an
improved environment [38,39]. On the other hand, self-reported engagement in risk-taking behaviors,
corresponding to a subtype of impulsivity, was associated with higher platelet MAO-B activity in
adult risky drivers [40]. In the same vein, platelet MAO-B activity was found to be negatively
correlated with expressed interpersonal violence in male suicide attempters [41], even though this
index was not affected by aggression against self in this study. Several factors may account for these
divergences, including the developmental stage of participants (namely, juvenile vs. adult offenders),
the seriousness of the committed criminal acts, the specific clinical scales, or the size of the cohorts
included in the studies. There are scarce data in the literature regarding the role of MAO-B and
its activity in the development of antisocial behavior and behavioral disorders in female subjects.
Malmberg and colleagues [31] reported an association between lower platelet MAO-B activity and
symptoms of oppositional defiant disorder. However, previously mentioned studies detected no
significant correlation between MAO-B activity and exposure to and/or expression of interpersonal
violence during childhood in female suicide attempters [41].
The idea that detention in a correctional facility may result in biological changes, such as MAO-B
activity elevation, is supported by several studies showing that this biochemical parameter is broadly
associated with several psychopathological conditions. Custody in juvenile halls has a marked impact
on poor health outcomes and a greater risk of psychopathology [42]. Youth in the correctional justice
system with a history of mental problems had higher levels of mental health symptoms and higher
scores on the symptoms listed in Brief Symptom Inventory (somatization, obsessive-compulsive
disorder, interpersonal sensitivity, depression, anxiety, paranoid ideation, and psychoticism) than adult
prisoners or the general population [43].
MAO-B oxidizes primarily trace amines, such as β-phenylethylamine, but also dopamine and
tyramine [44]. However, in tissues and cells where its isoenzyme MAO-A is absent, such as platelets,
MAO-B takes its role, including the degradation of serotonin and norepinephrine [45]. While MAO-B
is most abundant in the brain (where it serves 80% of total MAO activity), platelets are one of its
major peripheral sources [45]. Platelets are used as easily obtainable noninvasive peripheral models of
central serotonergic neurons [46], since they share some similar processes and contain some identical
components [47,48]. In view of these arguments, it has been proposed that platelet MAO-B activity
can be considered as a proxy of central serotonergic functions [10,39]. At the same time, however,
the relationship between MAO-B activity and alterations in monoamine contents is likely bidirectional,
depending on the origin and nature of these aberrances. For example, while a reduction in MAO-B
levels driven by genetic alterations is expected to produce elevations in several monoamine levels
(depending on the specific local contribution of this enzyme to monoamine metabolism) [14], increased
plasma concentrations of monoamine neurotransmitters may result in compensatory upregulation of
MAO-B, particularly in cells that do not display MAO-A, such as platelets. This perspective suggests
that both increased and decreased platelet MAO-B activity may be associated with similar deviations
of blood monoamine levels, as well as the corresponding psychopathological trait. As mentioned
above, rich evidence has shown that multiple neuropsychiatric conditions and behavioral phenotypes
have been associated with both elevations and reductions of platelet MAO-B in comparison with
nonaffected controls [8,12,23,30,45,49–60]. Thus, given the high prevalence of psychopathology among
detainees [61], it is likely that our finding of elevated MAO-B activity may signify a higher risk of
mental disorders in this population.
MAOB rs1799836 polymorphism was not significantly associated with CD, living in a juvenile
correctional facility, court convictions, attempted murder or committed property crime, or the PCL-YV,
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OAS-M, and CBCL scores. In line with this finding, MAOB rs1799836 was not related to autism
in children [62,63], severe agitation in patients with schizophrenia, CD, PTSD [23,30], anger-related
traits and aggression in suicidal participants and controls [64], aggression determined using the
Brown–Goodwin questionnaire [65], alcohol dependence [18], positive symptoms in schizophrenia [66],
or negative emotionality in healthy subjects [67]. In contrast to our data, a moderate association of the
G allele with higher scores on the Spontaneous Aggression subscale from the Freiburg Aggression
Scale in alcohol-dependent patients [17], and the association with the development of schizophrenia
in Han Chinese patients [68], but not in Turkish patients [69], was reported. MAOB rs1799836
might not be directly associated with CD or with delinquent behavior, but in a haplotype analysis
with other polymorphisms, such as MAOA rs6323T [68] or MAOB rs1799836, rs10521432, rs6651806,
and rs590551 [67], it might show significant association with altered behaviors. Differences in ethnicity,
heterogeneity in the diagnoses and sample characteristics [70], gender, age, smaller sample size
of cases/controls leading to lower power analysis might explain the divergent results. As recently
summarized [6], in a complicated entity such as CD, some association studies proposed a number of
suggestive signals, but with great inconsistencies across the studies. In addition, CD is associated with
complex interaction of genetic and environmental factors [6]. To dissect this complex disease, we also
evaluated the association of PCL-YV, OAS-M, and CBCL scores with MAOB rs1799836. However,
we could not confirm the significant association of MAOB rs1799836 with complex psychiatric and
behavioral outcomes in children and adolescents, such as CD (present study), ADHD or autism [62],
alcohol dependence [18] or PTSD [29,30] in adults. Therefore, we are reporting negative genetic results,
but corrected for all possible confounders. Our present and previous results and the results from other
studies suggest no relationship between MAOB rs1799836 polymorphism and CD, living in a juvenile
correctional facility, court convictions, or criminal/delinquent behavior. This is in line with results from
the GWAS study that detected no evidence of significant association between any of the MAO genes
and CD [71].
In agreement with all our and other previous data [17,18,23,28–30,72], platelet MAO-B activity
was not affected by the presence of the A or G allele of the MAOB rs1799836 polymorphism, and temper
previous evidence in vitro [73,74] or in a small number of subjects [75] that supported a possible role
of this polymorphism on MAO-B activity.
Strengths of this study include the inclusion of medication-free ethnically homogeneous youth,
determination of one biochemical and one genetic marker, male gender, detailed clinical evaluation of
the diagnosis, symptoms, and behaviors by child psychiatrists and a psychologist, the use of PCL-YV,
OAS-M, and CBCL to measure delinquent behavior and psychopathy, statistical power set to 0.80,
the needed sample size and detailed statistical analysis. Conversely, key limitations of this study are
that our genetic analyses were limited to only one polymorphism in the MAOB gene and that we were
not able to include female subjects. Although the total sample size was adequate (N = 289), division
into specific groups with unequal sample sizes (117 subjects detained in the juvenile correctional facility
with CD and 65 without the diagnosis of CD, 26 outpatients with CD, and 81 mentally healthy controls)
should be considered as another possible limitation of the study, especially while exploring a possible
association of CD or delinquent behavior with MAOB rs1799836 polymorphism.
5. Conclusions
In conclusion, our study revealed that platelet MAO-B activity was significantly higher in detained
youths, but was not affected by smoking, age, and presence of CD. It was associated with verbal
aggression and with living in a correctional facility. MAOB rs1799836 polymorphism was not associated
with CD-related phenotypes. Our data should be used for larger meta-analyses and confirmed or
rejected in independent studies. If these data are confirmed, future prospective studies are warranted
to elucidate whether the observed changes in platelet MAO-B activity reflect a biological consequence
of, or a risk factor for juvenile detention, and elucidate the underlying mechanisms.
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